A team of researchers at the Facility for Rare Isotope Beams (FRIB) at Michigan State University (MSU) has discovered that ...

It was a simple question asked over lunch in 1950. Enrico Fermi, the Nobel Prize-winning physicist who helped usher in the ...

Skyrizi (risankizumab) is the first IL-23-selective drug to be cleared for the inflammatory bowel disease – ahead of rivals like Johnson & Johnson's Tremfya (guselkumab), and Sun Pharma's Ilumya ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease (IBD ...

Discovery of a bicyclic peptide inhibitor of cell wall biosynthesis in the Enterobacterales demonstrates applicability of a modified phage display platform to antibiotic discovery and development ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated ...

For the first time in nearly 30 years, scientists have discovered the heaviest atomic nucleus ever observed that decays by ...